As previously reported, BofA initiated coverage of Ambiq Micro (AMBQ) with a Neutral rating and $42 price target The manufacturer of ultra-low-power processors for data/AI processing in smartwatches and health-related wearables, is still more than three years away from profitability, requires heavy expenses for future growth, and is dependent on two to three customers whose products are cyclical and competitive by nature, the analyst tells investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMBQ:
- Ambiq Micro initiated with a Neutral at BofA
- Ambiq Micro initiated with a Buy at Needham
- Ambiq Micro: Strategic Positioning and Growth Prospects in the Semiconductor Industry
- Ambiq Micro, Inc.: Strategic Positioning and Growth Potential in Edge AI Market with ‘SPOT’ and ‘Atomiq’ Platforms
- Ambiq Micro initiated with a Neutral at UBS